Varex Imaging Beheer
Beheer criteriumcontroles 2/4
De CEO Varex Imaging is Sunny Sanyal, benoemd in Jan2017, heeft een ambtstermijn van 7.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 4.52M, bestaande uit 17% salaris en 83% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.38% van de aandelen van het bedrijf, ter waarde $ 2.60M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.5 jaar en 7.6 jaar.
Belangrijke informatie
Sunny Sanyal
Algemeen directeur
US$4.5m
Totale compensatie
| Percentage CEO-salaris | 17.0% |
| Dienstverband CEO | 7.8yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 6.5yrs |
| Gemiddelde ambtstermijn bestuur | 7.6yrs |
Recente managementupdates
Recent updates
There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
Nov 07
Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Oct 22Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Sep 11Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
Aug 20We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Is There Now An Opportunity In Varex Imaging Corporation (NASDAQ:VREX)?
Oct 29Varex Imaging (NASDAQ:VREX) Hasn't Managed To Accelerate Its Returns
Sep 27What Is Varex Imaging Corporation's (NASDAQ:VREX) Share Price Doing?
Jul 21These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Reasonably Well
Jun 15Is It Too Late To Consider Buying Varex Imaging Corporation (NASDAQ:VREX)?
Mar 25Varex Imaging Corporation's (NASDAQ:VREX) CEO Might Not Expect Shareholders To Be So Generous This Year
Feb 04Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 31Returns On Capital At Varex Imaging (NASDAQ:VREX) Paint A Concerning Picture
Dec 22What Does Varex Imaging Corporation's (NASDAQ:VREX) Share Price Indicate?
Nov 08Varex Imaging (NASDAQ:VREX) Has A Pretty Healthy Balance Sheet
Oct 11Investors Could Be Concerned With Varex Imaging's (NASDAQ:VREX) Returns On Capital
Sep 01Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 06Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 27 2024 | n/a | n/a | -US$48m |
| Jun 28 2024 | n/a | n/a | US$34m |
| Mar 29 2024 | n/a | n/a | US$42m |
| Dec 29 2023 | n/a | n/a | US$45m |
| Sep 29 2023 | US$5m | US$766k | US$48m |
| Jun 30 2023 | n/a | n/a | US$29m |
| Mar 31 2023 | n/a | n/a | US$29m |
| Dec 30 2022 | n/a | n/a | US$32m |
| Sep 30 2022 | US$4m | US$715k | US$30m |
| Jul 01 2022 | n/a | n/a | US$26m |
| Apr 01 2022 | n/a | n/a | US$30m |
| Dec 31 2021 | n/a | n/a | US$25m |
| Oct 01 2021 | US$5m | US$637k | US$17m |
| Jul 02 2021 | n/a | n/a | -US$18m |
| Apr 02 2021 | n/a | n/a | -US$58m |
| Jan 01 2021 | n/a | n/a | -US$63m |
| Oct 02 2020 | US$4m | US$585k | -US$58m |
| Jul 03 2020 | n/a | n/a | -US$23m |
| Apr 03 2020 | n/a | n/a | US$4m |
| Jan 03 2020 | n/a | n/a | US$11m |
| Sep 27 2019 | US$3m | US$620k | US$16m |
| Jun 28 2019 | n/a | n/a | US$7m |
| Mar 29 2019 | n/a | n/a | US$13m |
| Dec 28 2018 | n/a | n/a | US$19m |
| Sep 28 2018 | US$3m | US$616k | US$28m |
Compensatie versus markt: De totale vergoeding ($USD 4.52M ) Sunny } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.17M ).
Compensatie versus inkomsten: De vergoeding van Sunny is gestegen terwijl het bedrijf verliesgevend is.
CEO
Sunny Sanyal (60 yo)
7.8yrs
Tenure
US$4,520,898
Compensatie
Mr. Sunny S. Sanyal serves as Member of Supervisory Board at MeVis Medical Solutions AG since September 24, 2020. Mr. Sanyal served as Deputy Chairman of Supervisory Board at MeVis Medical Solutions AG sin...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7.8yrs | US$4.52m | 0.38% $ 2.6m | |
| CFO & Principal Accounting Officer | 4.3yrs | US$1.52m | 0.19% $ 1.3m | |
| Chief Legal Officer | 7.8yrs | US$1.12m | 0.0011% $ 7.8k | |
| Senior VP & GM of X-Ray Sources | 7.8yrs | US$1.06m | 0.15% $ 1.0m | |
| Senior VP & GM of X-ray Detectors | 6.3yrs | US$1.07m | 0.050% $ 339.2k | |
| Director of Investor Relations | no data | geen gegevens | geen gegevens | |
| Vice President of Medical Global Sales & Marketing | 1.8yrs | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 1.7yrs | geen gegevens | geen gegevens | |
| VP & MD for China | 6.7yrs | geen gegevens | geen gegevens |
6.5yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van VREX is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7.8yrs | US$4.52m | 0.38% $ 2.6m | |
| Independent Director | 7.8yrs | US$262.49k | 0.067% $ 459.2k | |
| Independent Director | 4.2yrs | US$244.99k | 0.029% $ 195.0k | |
| Independent Chairman of the Board | 6.6yrs | US$297.49k | 0.087% $ 594.8k | |
| Independent Director | 2.3yrs | US$247.99k | 0% $ 0 | |
| Independent Director | 7.8yrs | US$247.49k | 0.045% $ 307.5k | |
| Independent Director | 7.6yrs | US$254.99k | 0.066% $ 451.6k |
7.6yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van VREX wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).